Aura Biosciences (AURA) Treasury Shares (2020 - 2026)

Aura Biosciences' Treasury Shares history runs 7 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• Quarterly Treasury Shares rose 19.42% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 19.42% YoY) and the FY2025 annual result came in at $2.7 million, up 69.33% from the prior year.
• Treasury Shares was $3.3 million for Q1 2026 at Aura Biosciences, up from $2.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.3 million in Q1 2026 and bottomed at $153950.0 in Q4 2022.
• A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares slumped 99.8% — and 2023, when it jumped 610.23%.
• Aura Biosciences' Treasury Shares stood at $153950.0 in 2022, then soared by 610.23% to $1.1 million in 2023, then jumped by 45.33% to $1.6 million in 2024, then surged by 69.33% to $2.7 million in 2025, then climbed by 22.13% to $3.3 million in 2026.
• Business Quant data shows AURA's Treasury Shares at $3.3 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.